{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:57:01Z","timestamp":1795039021762,"version":"4.10.2"},"reference-count":34,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"17","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2020,6,10]]},"abstract":"<jats:sec><jats:title>PURPOSE<\/jats:title><jats:p> Patients with B-cell acute lymphoblastic leukemia who experience relapse after or are resistant to CD19-targeted immunotherapies have limited treatment options. Targeting CD22, an alternative B-cell antigen, represents an alternate strategy. We report outcomes on the largest patient cohort treated with CD22 chimeric antigen receptor (CAR) T cells. <\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS AND METHODS<\/jats:title><jats:p> We conducted a single-center, phase I, 3 + 3 dose-escalation trial with a large expansion cohort that tested CD22-targeted CAR T cells for children and young adults with relapsed\/refractory CD22<jats:sup>+<\/jats:sup> malignancies. Primary objectives were to assess the safety, toxicity, and feasibility. Secondary objectives included efficacy, CD22 CAR T-cell persistence, and cytokine profiling. <\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p> Fifty-eight participants were infused; 51 (87.9%) after prior CD19-targeted therapy. Cytokine release syndrome occurred in 50 participants (86.2%) and was grade 1-2 in 45 (90%). Symptoms of neurotoxicity were minimal and transient. Hemophagocytic lymphohistiocytosis\u2013like manifestations were seen in 19\/58 (32.8%) of subjects, prompting utilization of anakinra. CD4\/CD8 T-cell selection of the apheresis product improved CAR T-cell manufacturing feasibility as well as heightened inflammatory toxicities, leading to dose de-escalation. The complete remission rate was 70%. The median overall survival was 13.4 months (95% CI, 7.7 to 20.3 months). Among those who achieved a complete response, the median relapse-free survival was 6.0 months (95% CI, 4.1 to 6.5 months). Thirteen participants proceeded to stem-cell transplantation. <\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p> In the largest experience of CD22 CAR T-cells to our knowledge, we provide novel information on the impact of manufacturing changes on clinical outcomes and report on unique CD22 CAR T-cell toxicities and toxicity mitigation strategies. The remission induction rate supports further development of CD22 CAR T cells as a therapeutic option in patients resistant to CD19-targeted immunotherapy. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.19.03279","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T20:17:50Z","timestamp":1586895470000},"page":"1938-1950","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":400,"title":["CD4\/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial"],"prefix":"10.1200","volume":"38","author":[{"given":"Nirali N.","family":"Shah","sequence":"first","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Highfill","sequence":"additional","affiliation":[{"name":"Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen","family":"Shalabi","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Yates","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Jin","sequence":"additional","affiliation":[{"name":"Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Wolters","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ombrello","sequence":"additional","affiliation":[{"name":"Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth M.","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci","family":"Martin","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Delbrook","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Little","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Ponduri","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Qin","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Dulau-Florea","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Salem","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryalice","family":"Stetler-Stevenson","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Panch","sequence":"additional","affiliation":[{"name":"Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh","family":"Tran","sequence":"additional","affiliation":[{"name":"Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal L.","family":"Mackall","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"},{"name":"Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Stroncek","sequence":"additional","affiliation":[{"name":"Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry J.","family":"Fry","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"},{"name":"University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children\u2019s Hospital of Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0612"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61403-3"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-769208"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709919"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3301"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609783"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0179"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85309"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-438002"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4441"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000241"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.148"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.183459"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0000000000000244"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2016.11.011"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000078"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001402"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000219"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1160-5"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2025"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000169"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-665547"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12320"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1020"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-019-00502-2"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000449"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3784"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0210-1"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-749101"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-793141"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0698"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1084"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.19.03279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T08:00:32Z","timestamp":1653811232000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.19.03279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":34,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020,6,10]]}},"alternative-id":["10.1200\/JCO.19.03279"],"URL":"https:\/\/doi.org\/10.1200\/jco.19.03279","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"2020-02-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}